Clinical Trial

Repurposing Low-Dose Clonidine for PTSD in Veterans

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Hypothesis: Veterans with PTSD prescribed clonidine will demonstrate improvements in PTSD symptoms, including daytime, nighttime, and sleep-related behaviors.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2021-05-03; most recent amendment 2026-03-25.
Status change: Not Yet Recruiting → Recruiting 2023-06-14
Trial Details
NCT Number NCT04877093
Lead Sponsor Wake Forest University Health Sciences
Conditions PTSD, Posttraumatic Stress Disorder, Sleep
Enrollment 32 participants
Start Date 2023-06-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-31